{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T09:33:03Z","timestamp":1763458383860,"version":"3.37.3"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ecl.2024.05.001","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T22:04:34Z","timestamp":1722290674000},"page":"321-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Updates in the Management of Type 1 Diabetes in Pregnancy"],"prefix":"10.1016","volume":"53","author":[{"given":"Alon Y.","family":"Mazori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol J.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ecl.2024.05.001_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00125-009-1633-z","article-title":"Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction","volume":"53","author":"Garc\u00eda-Patterson","year":"2010","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.ecl.2024.05.001_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/dia.2021.0112","article-title":"Longitudinal Observation of Insulin Use and Glucose Sensor Metrics in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitors and Insulin Pumps: The LOIS-P Study","volume":"23","author":"O\u2019Malley","year":"2021","journal-title":"Diabetes Technol Therapeut"},{"issue":"8","key":"10.1016\/j.ecl.2024.05.001_bib3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1089\/dia.2021.0479","article-title":"Hypoglycemia in Prospective Multicenter Study of Pregnancies with Pre-Existing Type 1 Diabetes on Sensor-Augmented Pump Therapy: The LOIS-P Study","volume":"24","author":"Kaur","year":"2022","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.ecl.2024.05.001_bib4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00125-011-2363-6","article-title":"Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy","volume":"55","author":"Murphy","year":"2012","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.ecl.2024.05.001_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S2213-8587(23)00116-X","article-title":"Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets [published correction appears in Lancet Diabetes Endocrinol. 2023 Oct;11(10):e12]","volume":"11","author":"Benhalima","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7445","key":"10.1016\/j.ecl.2024.05.001_bib6","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/bmj.38043.583160.EE","article-title":"Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands","volume":"328","author":"Evers","year":"2004","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.ecl.2024.05.001_bib7","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.2337\/diacare.27.12.2819","article-title":"Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study","volume":"27","author":"Jensen","year":"2004","journal-title":"Diabetes Care"},{"issue":"46","key":"10.1016\/j.ecl.2024.05.001_bib8","doi-asserted-by":"crossref","first-page":"80679","DOI":"10.18632\/oncotarget.20952","article-title":"Maternal and fetal outcomes of pregnant women with type 1 diabetes, a national population study","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ecl.2024.05.001_bib9","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1210\/clinem\/dgac464","article-title":"Diabetic Ketoacidosis in Pregnancy: Clinical Risk Factors, Presentation, and Outcomes","volume":"107","author":"Dhanasekaran","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2024.05.001_bib10","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.2337\/dc23-S015","article-title":"Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.ecl.2024.05.001_bib11","doi-asserted-by":"crossref","first-page":"e0237571","DOI":"10.1371\/journal.pone.0237571","article-title":"Systematic review and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes","volume":"15","author":"Wahabi","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.001_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/09286580701396720","article-title":"Overview of epidemiologic studies of diabetic retinopathy","volume":"14","author":"Klein","year":"2007","journal-title":"Ophthalmic Epidemiol"},{"issue":"10","key":"10.1016\/j.ecl.2024.05.001_bib13","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2337\/diacare.24.10.1739","article-title":"Pregnancy outcome in type 1 diabetic women with microalbuminuria","volume":"24","author":"Ekbom","year":"2001","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.ecl.2024.05.001_bib14","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"10110","key":"10.1016\/j.ecl.2024.05.001_bib15","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomized controlled trial [published correction appears in Lancet. 2017 Nov 25;390(10110):2346]","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ecl.2024.05.001_bib16","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2337\/dc19-2527","article-title":"Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes","volume":"43","author":"Scott","year":"2020","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.ecl.2024.05.001_bib17","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00125-019-4904-3","article-title":"Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters","volume":"62","author":"Murphy","year":"2019","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.ecl.2024.05.001_bib18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00125-019-4850-0","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies","volume":"62","author":"Kristensen","year":"2019","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.ecl.2024.05.001_bib19","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/dme.14046","article-title":"Modelling potential cost savings from use of real-time continuous glucose monitoring in pregnant women with Type 1 diabetes","volume":"36","author":"Murphy","year":"2019","journal-title":"Diabet Med"},{"issue":"7","key":"10.1016\/j.ecl.2024.05.001_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrendo.2017.39","article-title":"Insulin analogues in type 1 diabetes mellitus: getting better all the time","volume":"13","author":"Mathieu","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"10.1016\/j.ecl.2024.05.001_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/dia.2011.0032","article-title":"Glycemic control and pregnancy outcomes in women with type 1 diabetes mellitus using lispro versus regular insulin: a systematic review and meta-analysis","volume":"13","author":"Gonz\u00e1lez Blanco","year":"2011","journal-title":"Diabetes Technol Therapeut"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.001_bib22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2337\/dc06-1887","article-title":"Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women","volume":"30","author":"Mathiesen","year":"2007","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.ecl.2024.05.001_bib23","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/dc11-2264","article-title":"Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes","volume":"35","author":"Mathiesen","year":"2012","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.ecl.2024.05.001_bib24","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1464-5491.2008.02485.x","article-title":"Perinatal outcomes associated with the use of glargine during pregnancy","volume":"25","author":"Di Cianni","year":"2008","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.001_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S2213-8587(22)00307-2","volume":"11","author":"Mathiesen","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.ecl.2024.05.001_bib26","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2337\/dc18-1437","article-title":"Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial","volume":"41","author":"Feig","year":"2018","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.001_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/dme.13861","article-title":"Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with Type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection","volume":"36","author":"Hauffe","year":"2019","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.001_bib28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5603\/GP.2019.0028","article-title":"Continuous subcutaneous insulin infusion reduces neonatal risk in pregnant women with type 1 diabetes mellitus","volume":"90","author":"Mantaj","year":"2019","journal-title":"Ginekol Pol"},{"issue":"17","key":"10.1016\/j.ecl.2024.05.001_bib29","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1056\/NEJMoa2303911","article-title":"Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes","volume":"389","author":"Lee","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ecl.2024.05.001_bib30","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2337\/dc23-0173","article-title":"At-Home Use of a Pregnancy-Specific Zone-MPC Closed-Loop System for Pregnancies Complicated by Type 1 Diabetes: A Single-Arm, Observational Multicenter Study","volume":"46","author":"Levy","year":"2023","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.ecl.2024.05.001_bib31","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.2337\/dc23-0882","article-title":"A\u00a0Randomized Trial of Closed-Loop Insulin Delivery Postpartum in Type 1 Diabetes","volume":"46","author":"Donovan","year":"2023","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.001_bib32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2337\/cd21-0028","article-title":"Inequities in health outcomes in children and adults with type 1 diabetes: data from the T1D exchange quality improvement collaborative","volume":"39","author":"Majidi","year":"2021","journal-title":"Clin Diabetes"},{"issue":"7","key":"10.1016\/j.ecl.2024.05.001_bib33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2024.05.001_bib34","first-page":"dc211182","article-title":"Unchanged prevalence of preeclampsia after implementation of prophylactic aspirin for all pregnant women with preexisting diabetes: a prospective cohort study","author":"Do","year":"2021","journal-title":"Diabetes Care"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852924000318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852924000318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T12:47:33Z","timestamp":1722775653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852924000318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0889852924000318"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2024.05.001","relation":{},"ISSN":["0889-8529"],"issn-type":[{"type":"print","value":"0889-8529"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates in the Management of Type 1 Diabetes in Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2024.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}